What benefits will you experience as a result of GH therapy?

Benefits of Growth Hormone (GH) Therapy

Your body relies on adequate growth hormone levels for efficient metabolism and healthy body composition. GH therapy aims to restore optimal GH levels in individuals with GH deficiency. GH is crucial for maintaining bone density and strength, regulating cholesterol balance, and promoting a healthy muscle-to-fat ratio. Supplementing GH can offer several benefits if you have a GH deficiency.

Improved Body Composition

GH treatment can help you achieve a better body shape. By restoring GH levels, you can attain a leaner physique and reduce excess fat through natural metabolic processes. Clinical studies have demonstrated a significant transformation of fat to lean mass in patients treated with GH for twelve months.

Reduced Body Fat Percentage

GH deficiency often leads to higher-than-ideal body fat. GH supplementation can help you naturally lose this excess fat. Maintaining extra body fat poses health risks, including increased cardiovascular problems and certain cancers. Clinical studies show that GH therapy leads to a significant reduction in total body fat, particularly abdominal fat, after 12 months of treatment. This fat loss is observed in both adult-onset and pediatric-onset AGHD patients treated with supplementary GH.

Improved Cholesterol Ratio

Maintaining a proper balance of good (HDL) and bad (LDL) cholesterol is vital. GH-deficient patients often have elevated bad cholesterol levels. GH therapy can lower bad cholesterol levels and restore a healthier balance. While GH therapy improves the cholesterol ratio, it typically does not affect total cholesterol or triglyceride levels. This improvement is seen in both adult-onset and pediatric-onset patients, although pediatric-onset patients may receive higher doses of Hypertropin. Adult-onset patients may not tolerate the higher dosages used for child-onset patients.

Improved Bone and Mineral Density (Specific Cases)

GH treatment can improve bone and mineral density in the spine, but this benefit is primarily observed in pediatric-onset patients treated with higher doses of Hypertropin. These patients may show improved mineral density in the spine. Adult-onset patients receiving standard adult dosages generally do not experience significant bone density improvements. Furthermore, pediatric-onset patients do not show increased mineral densities in other bones.